Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma

References

• Bonvalot S, Rimareix F, Causeret S, Le Pechoux C, Boulet B, Terrier P, et al. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol 2009; 16: 3350–3357
   PubMed Web of Science ®Google Scholar
• Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Lienard D, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg 1996; 224: 756–764
   PubMed Web of Science ®Google Scholar
• Grunhagen DJ, de Wilt JH, Graveland WJ, Verhoef C, van Geel AN, Eggermont AM. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer 2006; 106: 1776–1784
   PubMed Web of Science ®Google Scholar
• Rossi CR, Foletto M, Mocellin S, Pilati PL, Campana L, Rubello D, et al. TNF-based limb perfusion for cutaneous melanoma in transit metastases: Suggestions for modification of the perfusional schedule. J Exp Clin Cancer Res 2003; 22: 103–107
   PubMed Web of Science ®Google Scholar
• Taeger G, Grabellus F, Podleska LE, Muller S, Ruchholtz S. Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities. Int J Hyperthermia 2008; 24: 193–203
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab OI, Grubbs E, Viglianti BL, Cheng TY, Ueno T, Ko S, et al. The role of hyperthermia in regional alkylating agent chemotherapy. Clin Cancer Res 2004; 10: 5919–5929
   PubMed Web of Science ®Google Scholar
• Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334: 1717–1725
   PubMed Web of Science ®Google Scholar
• Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001; 104: 487–501
   PubMed Web of Science ®Google Scholar
• Lejeune FJ, Lienard D, Matter M, Ruegg C. Efficiency of recombinant human TNF in human cancer therapy. Cancer Immun 2006; 6: 6
   PubMedGoogle Scholar
• ten Hagen TL, Eggermont AM. Changing the pathophysiology of solid tumours: The potential of TNF and other vasoactive agents. Int J Hyperthermia 2006; 22: 241–246
   PubMed Web of Science ®Google Scholar
• Grabellus F, Podleska LE, Bjerlestam S, Sheu SY, Lendemans S, Schmid KW, et al. Increased shedding of soluble TNF-receptor 1 during hyperthermic TNF-alpha-based isolated limb perfusion. Int J Hyperthermia 2011; 27: 33–41
   PubMed Web of Science ®Google Scholar
• Ferrero E, Zocchi MR, Magni E, Panzeri MC, Curnis F, Rugarli C, et al. Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability. Am J Physiol Cell Physiol 2001; 281: C1173–1179
   PubMed Web of Science ®Google Scholar
• Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, Gnant MF, et al. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: Relationship between the procoagulant and permeability effects of TNF. Blood 2002; 100: 1334–1339
   PubMed Web of Science ®Google Scholar
• Kallinowski F, Moehle R, Schaefer C, Vaupel P. Effects of tumor necrosis factor-alpha on tumor blood flow and hyperthermic treatment. Onkologie 1989; 12: 131–135
   PubMedGoogle Scholar
• Kerkar S, Williams M, Blocksom JM, Wilson RF, Tyburski JG, Steffes CP. TNF-alpha and IL-1beta increase pericyte/endothelial cell co-culture permeability. J Surg Res 2006; 132: 40–45
   PubMed Web of Science ®Google Scholar
• Nooijen PT, Manusama ER, Eggermont AM, Schalkwijk L, Stavast J, Marquet RL, et al. Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: A histopathological, immunohistochemical and electron microscopical study. Br J Cancer 1996; 74: 1908–1915
   PubMed Web of Science ®Google Scholar
• Watanabe N, Niitsu Y, Umeno H, Kuriyama H, Neda H, Yamauchi N, et al. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res 1988; 48: 2179–2183
   PubMed Web of Science ®Google Scholar
• de Wilt JH, Manusama ER, van Tiel ST, van Ijken MG, ten Hagen TL, Eggermont AM. Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. Br J Cancer 1999; 80: 161–166
   PubMed Web of Science ®Google Scholar
• Vrouenraets BC, Eggermont AM, Hart AA, Klaase JM, van Geel AN, Nieweg OE, et al. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone. Eur J Surg Oncol 2001; 27: 390–395
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Dings R, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: Role of tumor vascular thermotolerance and relevant physiological factors. Int J Hyperthermia 2010; 26: 256–263
   PubMed Web of Science ®Google Scholar
• Grabellus F, Kraft C, Sheu-Grabellus SY, Bauer S, Podleska LE, Lauenstein TC, et al. Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-alpha and melphalan. J Surg Oncol 2011; 103: 371–379
   PubMed Web of Science ®Google Scholar
• Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996; 56: 941–943
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Alsner J, Keller J, Nielsen OS, Jensen OM, Horsman MR, et al. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations. Br J Cancer 2001; 84: 1070–1075
   PubMed Web of Science ®Google Scholar
• Lassau N, Lamuraglia M, Vanel D, Le Cesne A, Chami L, Jaziri S, et al. Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: Prospective study of 49 cases. Ann Oncol 2005; 16: 1054–1060
   PubMed Web of Science ®Google Scholar
• Vanel D, Bonvalot S, Guinebretiere JM, Petrow P, Dromain C, Caillet H. MR imaging in the evaluation of isolated limb perfusion: A prospective study of 18 cases. Skeletal Radiol 2004; 33: 150–156
   PubMed Web of Science ®Google Scholar